Citadel Advisors’s Aehr Test Systems AEHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$71.4M Buy
743,000
+591,400
+390% +$54M 0.01% 1238
2026
Q1
$5.62M Sell
151,600
-136,000
-47% -$4.35M ﹤0.01% 4154
2025
Q4
$5.81M Sell
287,600
-29,900
-9% -$723K ﹤0.01% 4047
2025
Q3
$9.56M Buy
317,500
+197,200
+164% +$4.27M ﹤0.01% 3350
2025
Q2
$1.56M Sell
120,300
-29,000
-19% -$276K ﹤0.01% 6187
2025
Q1
$1.09M Buy
149,300
+91,600
+159% +$1.01M ﹤0.01% 6775
2024
Q4
$960K Sell
57,700
-5,600
-9% -$74.7K ﹤0.01% 7107
2024
Q3
$813K Sell
63,300
-25,200
-28% -$364K ﹤0.01% 7270
2024
Q2
$989K Sell
88,500
-183,200
-67% -$2.13M ﹤0.01% 6601
2024
Q1
$3.37M Buy
271,700
+55,200
+25% +$920K ﹤0.01% 4592
2023
Q4
$5.74M Sell
216,500
-86,600
-29% -$2.53M ﹤0.01% 3589
2023
Q3
$13.9M Sell
303,100
-9,000
-3% -$417K ﹤0.01% 2284
2023
Q2
$12.9M Sell
312,100
-193,200
-38% -$6.34M ﹤0.01% 2358
2023
Q1
$15.7M Buy
505,300
+353,100
+232% +$11.4M ﹤0.01% 2210
2022
Q4
$3.06M Sell
152,200
-71,000
-32% -$1.52M ﹤0.01% 4718
2022
Q3
$3.15M Buy
223,200
+187,100
+518% +$2.52M ﹤0.01% 4720
2022
Q2
$271K Sell
36,100
-40,500
-53% -$336K ﹤0.01% 10029
2022
Q1
$778K Sell
76,600
-116,000
-60% -$1.48M ﹤0.01% 8283
2021
Q4
$4.66M Buy
192,600
+96,600
+101% +$1.89M ﹤0.01% 4433
2021
Q3
$1.31M Buy
+96,000
New +$690K ﹤0.01% 7439

Other funds holding AEHR

Citadel Advisors's AEHR Position: Q2 2026 in Review

Citadel Advisors increased its Aehr Test Systems (AEHR) stake by 184% in Q2 2026, buying an estimated $23.7M and bringing the position to 400,732 shares worth $38.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1829.

Citadel Advisors first reported a position in AEHR in Q2 2016 and has held it in 21 quarters since. 262 funds tracked by Wall St. Rank hold AEHR as of Q2 2026.

  • Citadel Advisors held 400,732 shares of Aehr Test Systems worth $38.5M as of Q2 2026.
  • Citadel Advisors bought 259,441 Aehr Test Systems shares in Q2 2026, an estimated $23.7M.
  • Aehr Test Systems made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #1829 holding.
  • Citadel Advisors first reported a position in Aehr Test Systems in Q2 2016 and has held it in 21 quarters since.
  • 262 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.